These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 9715090)

  • 21. gp130-specific antisense oligonucleotides inhibit IL-6 signal inducing junB mRNA transcription in the human hepatoma cell line, HepG2.
    Varga VL; Fülöp AK; Holub MC; Tóth S; Szalai C; Falus A
    Cell Biol Int; 2001; 25(8):835-40. PubMed ID: 11482910
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Signal through gp130 activated by soluble interleukin (IL)-6 receptor (R) and IL-6 or IL-6R/IL-6 fusion protein enhances ex vivo expansion of human peripheral blood-derived hematopoietic progenitors.
    Kimura T; Wang J; Minamiguchi H; Fujiki H; Harada S; Okuda K; Kaneko H; Yokota S; Yasukawa K; Abe T; Sonoda Y
    Stem Cells; 2000; 18(6):444-52. PubMed ID: 11072033
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of pre-B cell colony-enhancing factor by STAT-3-dependent interleukin-6 trans-signaling: implications in the pathogenesis of rheumatoid arthritis.
    Nowell MA; Richards PJ; Fielding CA; Ognjanovic S; Topley N; Williams AS; Bryant-Greenwood G; Jones SA
    Arthritis Rheum; 2006 Jul; 54(7):2084-95. PubMed ID: 16802343
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Soluble interleukin-6 receptor alpha inhibits the cytokine-Induced fractalkine/CX3CL1 expression in human vascular endothelial cells in culture.
    Matsumiya T; Imaizumi T; Fujimoto K; Cui X; Shibata T; Tamo W; Kumagai M; Tanji K; Yoshida H; Kimura H; Satoh K
    Exp Cell Res; 2001 Sep; 269(1):35-41. PubMed ID: 11525637
    [TBL] [Abstract][Full Text] [Related]  

  • 25. C-terminal peptides of interleukin-6 modulate the expression of junB protooncogene and the production of fibrinogen by HepG2 cells.
    Igaz P; Bösze S; Tóth S; Falus A; Hudecz F
    Biol Chem; 2001 Apr; 382(4):669-76. PubMed ID: 11405230
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of interleukin-15 and interleukin-18 in the secretion of sIL-6R and sgp130 by human neutrophils.
    Jablonska E; Marcinczyk M
    Mediators Inflamm; 2003 Jun; 12(3):179-83. PubMed ID: 12857602
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Cell endocytosis of the complex interleukin-6-soluble interleukin-6 receptor and its intralysosomal degradation].
    Korolenko TA; Heinrich PK; Hemmann U; Weiergraber O; Dittrich E; Graeve L
    Biull Eksp Biol Med; 1997 Nov; 124(11):527-9. PubMed ID: 9471247
    [No Abstract]   [Full Text] [Related]  

  • 28. [Cytokines, their receptors and inhibitors. Importance in laboratory diagnosis of rheumatoid arthritis].
    Dobryszycka W; Rekas A
    Postepy Hig Med Dosw; 1993; 47(6):415-36. PubMed ID: 8208627
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Signals and signal processing--VI. Receptor expression and release-- regulatory role of membrane bound and soluble receptors.
    Mol Immunol; 1990 Dec; 27(12):1163-359. PubMed ID: 2274059
    [No Abstract]   [Full Text] [Related]  

  • 30. Biological functions and therapeutic opportunities of soluble cytokine receptors.
    Lokau J; Garbers C
    Cytokine Growth Factor Rev; 2020 Oct; 55():94-108. PubMed ID: 32386776
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reverse signaling through membrane-bound interleukin-15.
    Budagian V; Bulanova E; Orinska Z; Pohl T; Borden EC; Silverman R; Bulfone-Paus S
    J Biol Chem; 2011 Mar; 286(10):8708. PubMed ID: 21495271
    [No Abstract]   [Full Text] [Related]  

  • 32. IL-6 transsignaling: the in vivo consequences.
    Jones SA; Richards PJ; Scheller J; Rose-John S
    J Interferon Cytokine Res; 2005 May; 25(5):241-53. PubMed ID: 15871661
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Interleukin-6 acts in different ways via soluble and membrane-bound receptors].
    Igaz P; Tóth S; Madurka I; Falus A
    Orv Hetil; 1998 Jul; 139(29):1741-4. PubMed ID: 9715090
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Soluble interleukin 6 (IL-6) receptor influences the expression of the protooncogene junB and the production of fibrinogen in the HepG2 human hepatoma cell line and primary rat hepatocytes.
    Igaz P; Tóth S; Rose-John S; Madurka I; Fejér G; Szalai C; Falus A
    Cytokine; 1998 Aug; 10(8):620-6. PubMed ID: 9722935
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Soluble IL-6 receptor potentiates the antagonistic activity of soluble gp130 on IL-6 responses.
    Müller-Newen G; Küster A; Hemmann U; Keul R; Horsten U; Martens A; Graeve L; Wijdenes J; Heinrich PC
    J Immunol; 1998 Dec; 161(11):6347-55. PubMed ID: 9834125
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interleukin-6 N-terminal peptides modulate the expression of junB protooncogene and the production of fibrinogen in HepG2 cells.
    Bosze S; Hudecz F; Igaz P; Ortutay Z; Csík G; Falus A; Tóth S
    Biol Chem; 2003 Mar; 384(3):409-21. PubMed ID: 12715892
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.